In HCC patients, the positivity of AFP-L3 is around 20–30%; AFP-L3 correlates with poor differentiation, indicating that AFP-L3 may have a prognostic value.[28–30] On the other hand, p53 is mutated in 25% of HCC patients. Here, TP53 is linked to hepatocellular carcinoma.